<p><!-- BEGIN THEIA POST SLIDER --></p>
<p> <br />
</p>
<div>
<p><span style="font-weight:400">When Treasury Secretary Scott Bessent engineered a unique deal with Argentina’s Javier Milei, Guy Nohra started paying attention to Bessent’s moves. </span></p>
<p><span style="font-weight:400">Nohra, a venture capitalist with over three decades of experience, knows a solid operator when he sees one.</span></p>
<p><span style="font-weight:400">In the Trump administration, Nohra says that guy is Scott Bessent. — The Daily Wire</span></p>
<p>* * *</p>
<p><span style="font-weight:400">After more than three decades investing in life sciences, co-founding Alta Partners and backing more than 180 breakthrough companies, I’ve learned a simple truth: innovation thrives when financial stability meets vision. Under Treasury Secretary Scott Bessent, America is delivering both.</span></p>
<p><span style="font-weight:400">This week’s $20 billion swap line with Argentina, paired with the U.S. purchase of Argentine pesos to stabilize markets, showed a different face of American leadership — one built on partnership rather than pressure. At home, Bessent’s confirmation that fiscal year 2025 closed with a lower deficit-to-GDP ratio than the year before signaled a welcome return to fiscal discipline. For investors like me, that message matters.</span></p>
<p><span style="font-weight:400">In biotech, one of the few if not the only sectors where pre-revenue companies go public in bull markets, a steady and clear hand at the Department of Treasury is a must. Secretary Bessent’s quiet confidence is a welcome change from Janet Yellen’s “inflation is transitory” approach. The life sciences public sector has been in a funk since 2021 and is finally showing signs of recovery.</span></p>
<p><span style="font-weight:400">Furthermore, venture funding in private life sciences companies has climbed roughly 25% year over year, according to PitchBook. That is not coincidence; it is cause and effect. Bessent’s push for clarity and transparency in financial markets helps all sectors, but especially fragile ecosystems such as biotechnology.</span></p>
<p><span style="font-weight:400">Bessent also understands how fiscal health drives innovation. In recent remarks to community-bank CEOs, he urged them to “go on the offense” by adopting fintech and AI. That was not banker talk; it was a blueprint for growth. By modernizing lending rules and keeping borrowing costs low, he has opened new paths for regional lenders to support early-stage biotechs and rural innovation hubs.</span></p>
<p><span style="font-weight:400">Some critics claim his attention to global markets, such as the Argentina initiative, distracts from domestic priorities. They miss the larger point. In life sciences, borders are illusions. A stable global economy ensures supply-chain reliability, research collaboration, and steady talent flow. Bessent’s diplomacy prevents the kind of market shocks that raise costs and choke investment at home.</span></p>
<p><span style="font-weight:400">What sets him apart is a blend of intellectual rigor and street-smart optimism, refined through years in global markets and at the helm of his own firm, Key Square Capital. He is not a bureaucrat trading in slogans but a market-tested operator who knows how to turn downturns into momentum. In his speech at the Federal Reserve’s Community Bank Conference, he described a future where small lenders and big ideas combine to help America out-innovate China in quantum computing, biologics, and sustainable manufacturing. For those of us funding the next generation of cures, that vision is a North Star.</span></p>
<p><span style="font-weight:400">As we approach a decade that could redefine human health — CRISPR 2.0, personalized medicine at scale, regenerative medicine — Scott Bessent’s steady leadership is providing the runway. His policies may not make flashy headlines, but they are quietly powering America’s next economic renaissance.</span></p>
<p><span style="font-weight:400">To my fellow investors, entrepreneurs, and policymakers: let’s double down on this moment. His 3% average GDP growth, 3% annual budget deficits (as a percentage of GDP), and three million barrel increase in domestic oil production are aggressive but achievable goals.</span></p>
<p><span style="font-weight:400">Let’s support the initiatives Bessent is advancing, from expanded R&;D incentives to bold public-private partnerships in health technology. The future of life sciences, and of American competitiveness, depends on it.</span></p>
<p>* * *</p>
<p><em><span style="font-weight:400">Guy Paul Nohra is Co-Founder of Alta Partners and Co-Founder of Alta Life Sciences Spain. He is a venture capitalist, philanthropist, and former GOP gubernatorial candidate for Nevada. He holds a BA from Stanford University and an MBA from Booth School of Business, University of Chicago.</span></em></p>
<p><em><span style="font-weight:400">The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.</span></em></p>
<p><strong><em>Join us now during our exclusive Deal of the Decade. Get everything for $7 a month. Not as fans. As fighters. Go to <a href="https://get.dailywire.com/subscribe/plus/" target="_blank" rel="noopener">DailyWire.com/Subscribe</a> to join now.</em></strong></p>
</div>
<div id="payed-article-paywall"><img alt="Create Free Account" src="https://dailywireplus-v2.imgix.net/hostimages1/Frame%201010105171.png"/></p>
<p>Continue reading this exclusive article and join the conversation, plus watch free videos on DW+</p>
<p><button class="subscribeCTA_freeAccountButton__3TBgh" data-paywall-action-type="read:create-free-account" data-testid="continue-reading-button-free" type="button">Create Free Account</button></p>
<p>Already a member?<!-- --> <button class="subscribeCTA_loginButton__LNt6K" data-paywall-action-type="read:login">Log in</button></p>
</div>
<p><br />
<br /><a href="https://www.dailywire.com/news/the-steady-hand-guiding-americas-economic-renaissance">Source link </a></p>
<p><!-- END THEIA POST SLIDER --></p>

The Steady Hand Guiding America’s Economic Renaissance
